US6365632B1ExpiredUtility
Treatment of orthostatic hypotension
Assignee: KNOLL PHARMACEUTICALS COMPANYPriority: Mar 19, 1999Filed: Mar 17, 2000Granted: Apr 2, 2002
Est. expiryMar 19, 2019(expired)· nominal 20-yr term from priority
A61K 31/137
72
PatentIndex Score
4
Cited by
8
References
12
Claims
Abstract
A compound of formula I or a pharmaceutically acceptable salt thereof in which R 1 and R 2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating orthostatic hypotension.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of treating orthostatic hypotension comprising administering to a human in need thereof a therapeutically effective amount of a compound of formula I,
an enantiomer or a pharmaceutically acceptable salt thereof in which R 1 and R 2 are independently H or methyl, in conjunction with a pharmaceutically acceptable diluent or carrier.
2. The method as claimed in claim 1 wherein the compound of formula I is N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride.
3. The method as claimed in claim 1 wherein the compound of formula I is N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride in the form of its monohydrate.
4. The method as claimed in claim 1 wherein the compound of formula I is (+) N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl-N-methylamine.
5. The method as claimed in claim 1 wherein the compound of formula I is (−)-N-{1-[1-(4-chlorophenyl)cyclobutyl-3-methylbutyl}-N-methylamine.
6. The method as claimed in claim 1 wherein the compound of formula I is (+)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine.
7. The method as claimed in claim 1 wherein the compound of formula I is (−)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine.
8. The method as claimed in claim 1 wherein the compound of formula I is (+) N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl-N-N-dimethylamine.
9. The method as claimed in claim 1 wherein the compound of formula I is (−)-N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-N-dimethylamine.
10. The method as claimed in claim 1 wherein the compound of formula I is (±)-N-{1-[1-(4-chlorophenyl)cyclobutyl-3-methylbutyl}-N-methylamine.
11. The method as claimed in claim 1 wherein the compound of formula I is (±)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine.
12. The method as claimed in claim 1 wherein the compound of formula I is (±)-N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-N-dimethylamine.Join the waitlist — get patent alerts
Track US6365632B1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.